Sanofi and Ad Scientiam partner to assess MS disability progression pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Ad Scientiam Launches International Study to Assess Disability Progression in multiple sclerosis with MSCopilot®Paris, 12 September, 2023 – Ad Scientiam, a global leader in digital biomarkers has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-.
Ad Scientiam Begins Global Study on MS Progression with MSCopilot miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
PARIS, FRANCE / ACCESSWIRE / September 12, 2023 / Ad Scientiam, a global leader in.